Lonza · 1 day ago
Sr. Engineer, Automation
Lonza is a global leader in life sciences operating across five continents, and they are seeking a Senior Automation Engineer to support pharmaceutical manufacturing operations. In this role, you will collaborate with cross-functional teams to enhance system reliability and drive continuous improvement through innovative automation solutions.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Support 24/7 operation of GMP process and facility equipment to ensure maximum uptime
Lead troubleshooting and resolve automation system issues
Manage vendors and suppliers for automation system implementation and support
Develop and maintain specifications and documentation for automation systems
Collaborate with IT/OT teams to ensure secure and reliable infrastructure
Mentor junior engineers and technicians
Drive improvements in automation systems through hardware/software upgrades
Qualification
Required
Associate's Degree (minimum) or Bachelor's Degree (preferred) in Automation, Electrical Engineering, or related field
Experience with industrial automation and controls in a manufacturing environment
Familiarity with Allen Bradley PLCs, HMI development, and FactoryTalk systems
Knowledge of SCADA, Building Automation Systems, and network infrastructure
Ability to support manufacturing operations on an on-call rotation
Strong troubleshooting skills and understanding of safety practices
Preferred
Experience in regulated industries such as biotech or pharmaceuticals
Benefits
Medical, dental, and vision insurance
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase